Prevention of Vasovagal Syncope by Pacing: How to Select Patients and Which Pacing Mode to Choose

  • M. Brignole
Conference paper


Despite the fact that vasovagal syncope is probably the most frequent of all causes of fainting, treatment strategies are as yet still based on an incomplete understanding of the pathophysiology of the faint. On the other hand, given the frequency with which the vasovagal syncope occurs, there is a wealth of clinical experience on which to draw. In the vast majority of cases, patients who seek medical advice after having experienced a vasovagal faint principally require reassurance and education regarding the nature of the condition. This assumption is derived from the knowledge of the benign nature of the disorder In particular, on the basis of a review of their medical history, patients should be informed of the likelihood of syncope recurrence. Initial advice should also include a review of typical premonitory symptoms, which may permit many individuals to recognize an impending episode and thereby avert a frank faint. Additional common sense measures such as avoidance of volume depletion and prolonged exposure to upright posture and/or hot, confining environments should also be discussed. In regard to these latter treatment concepts, formal randomized studies are not available, but physiological evidence and clinical experience are sufficient warrant.


Tilt Testing Vasovagal Syncope Syncope Recurrence Neurocardiogenic Syncope North American Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sutton R, Brignole M, Menozzi C et al (2000) Dual-chamber pacing is efficacious in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomized study. Circulation 102:294–299PubMedCrossRefGoogle Scholar
  2. 2.
    Brignole M, Menozzi C, Gianfranchi L et al (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70:339–342PubMedCrossRefGoogle Scholar
  3. 3.
    Sheldon R, Rose S, Flanagan P et al (1996) Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 93:973–981PubMedCrossRefGoogle Scholar
  4. 4.
    Natale A, Geiger MJ, Maglio C et al (1995) Recurrence of neurocardiogenic syncope without pharmacologic interventions. Am J Cardiol 77:1001–1003CrossRefGoogle Scholar
  5. 5.
    Brignole M, Alboni P, Benditt D et al (2001) Task Force on Syncope, European Society of Cardiology: guidelines on management (diagnosis and treatment) of syncope. Eur Heart J (in press)Google Scholar
  6. 6.
    Connolly SJ, Sheldon R, Roberts RS, Gent M (1999) Vasovagal pacemaker study investigators. Cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20PubMedCrossRefGoogle Scholar
  7. 7.
    Sutton R, Petersen M, Brignole M et al (1992) Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 3:180–183Google Scholar
  8. 8.
    Brignole M, Menozzi C, Del Rosso A et al (2000) New classification of haemodyna-mics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-synco-pal phase of the tilt test without and with nitroglycerin challenge. Europace 2:66–76PubMedCrossRefGoogle Scholar
  9. 9.
    Ammirati F, Colivicchi F, Toscano S et al (1998) DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope. Pacing Clin Electrophysiol 21:2178–2181PubMedCrossRefGoogle Scholar
  10. 10.
    Brignole M, Menozzi C (1997) Methods other than tilt testing for diagnosing neurocardiogenic (neurally mediated) syncope. Pacind Clin Electrophysiol 20:795–780CrossRefGoogle Scholar
  11. 11.
    Shah CD, Thakur R, Xie B, Patrak P (1999) Dual chamber pacing for neurally mediated syncope with a prominent cardioinhibitory component. Pacing Clin Electrophysiol 22:999–1003PubMedCrossRefGoogle Scholar
  12. 12.
    Petersen MEV, Chamberlain-Webber R, Fizpatrick AP et al (1994) Permanent pacing for cardio-inhibitory malignant vasovagal syndrome. Br Heart J 71:274–281PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Benditt D, Sutton R, Gammage M et al (1997) Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pacing Clin Electrophysiol 20 (part II):832–839PubMedCrossRefGoogle Scholar
  14. 14.
    Sheldon R, Koshman ML, Wilson W et al (1998) Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally-mediated syncope. Am J Cardiol 81:158–162PubMedCrossRefGoogle Scholar
  15. 15.
    Moya A, Brignole M, Menozzi C et al (2001) The mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation (in press)Google Scholar

Copyright information

© Springer-Verlag Italia 2002

Authors and Affiliations

  • M. Brignole
    • 1
  1. 1.Department of Cardiology and Arrhythmologic CenterOspedali RiunitiLavagnaItaly

Personalised recommendations